Sotyktu

Sotyktu (deucravacitinib) is a prescription medication used to treat Plaque psoriasis. A once-daily pill for moderate-to-severe plaque psoriasis that can produce clearer skin.

Selectively blocks the TYK2 enzyme involved in the immune signaling that drives psoriasis.

Commonly reported side effects of Sotyktu include Common cold symptoms, Increased infections, Cold sores, Mouth sores, and Increased liver enzymes. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Sotyktu has notable warnings and precautions. Tell your doctor about your medical history and any other medicines or supplements you take before starting Sotyktu.

The active ingredient in Sotyktu is deucravacitinib, which belongs to a class of medicines known as TYK2 Inhibitor.

Sotyktu is manufactured by Bristol-Myers Squibb. It was first approved in 2022.

You may be able to lower the cost of Sotyktu by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.